July 3, 2008Abbott rises after FDA approves Xience V stent - MSN MoneyCentral Abbott rises after FDA approves Xience V stent - MSN MoneyCentral
NEW YORK (AP) - Shares of Abbott Laboratories rose Thursday after regulators approved its drug-coated Xience V stent for sale. The Food and Drug Administration approved the stent late Wednesday, and Abbott expects it to take between 25 percent and 30 Source: news.moneycentral.msn.com FDA Advisory Committee Recommends Cardiovascular Safety Studies for - Medscape News July 3, 2008 — New diabetes drugs should be subjected to studies to rule out cardiovascular risk, the FDA 's Endocrinologic and Metabolic Drugs Advisory Committee decided at a meeting this week. But the specifics of what exactly those studies Source: www.medscape.com FDA approves Boston Scientific stent - Minneapolis-St Paul Business Journal More funding, new leadership bolster Sinexus [San Jose] Boston Sci sells investments for $140M [Mpls./St. Paul] Weaving a tale of two med techs in Rhode Island [Mass High Tech] Boston Scientific Corp. announced Wednesday that the U.S. Food and Drug Source: twincities.bizjournals.com # posted by Network @ 3:00 PM
 |
Subscribe to Posts [Atom]